Development of PEG-PLGA based Intravenous Low Molecular Weight Heparin (LMWH) Nanoparticles Intended to Treat Venous Thrombosis. [electronic resource]
- Current drug delivery 2016
- 698-710 p. digital
Publication Type: Journal Article
1875-5704
10.2174/1567201813666160114092743 doi
Administration, Intravenous Animals Anticoagulants--administration & dosage Blood Coagulation--drug effects Calorimetry, Differential Scanning Crystallography, X-Ray Delayed-Action Preparations Disease Models, Animal Drug Carriers Drug Compounding Drug Stability Heparin, Low-Molecular-Weight--administration & dosage Male Microscopy, Electron, Scanning Microscopy, Electron, Transmission Nanoparticles Nanotechnology Partial Thromboplastin Time Particle Size Polyesters--chemistry Polyethylene Glycols--chemistry Rats, Wistar Solubility Technology, Pharmaceutical--methods Tissue Distribution Venous Thrombosis--blood